|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3089741 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15700082.9 |
| Date of filing the European patent application | 2015-01-02 | |
| (97) | Date of publication of the European application | 2016-11-09 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-10 |
| (46) | Date of publication of the claims translation | 2021-06-10 |
| (86) | Number | PCT/GB2015/050001 |
| Date | 2015-01-02 |
| (87) | Number | WO 2015/101791 |
| Date | 2015-07-09 |
| (30) | Number | Date | Country code |
| 201400034 | 2014-01-02 | GB |
| (72) |
WILSON, David, GB
FINNIE, Cindy, GB
RAW, Steven Anthony, GB
|
| (73) |
Astrazeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Farmacinės kompozicijos apimančios AZD9291 |
| PHARMACEUTICAL COMPOSITIONS COMPRISING AZD9291 |
| Payment date | Validity (years) | Amount | |
| 2025-12-17 | 12 | 289.00 EUR |
| 2027-01-02 |